First human test of new Cancer-Fighting antibody begins
Disease control
Completed
This early-stage study tested the safety and initial effectiveness of a new experimental drug called KBA1412 in adults with advanced solid tumors that have stopped responding to standard treatments. The trial tested KBA1412 given alone and in combination with an existing immunoth…
Phase: PHASE1 • Sponsor: Kling Biotherapeutics B.V. • Aim: Disease control
Last updated Mar 16, 2026 15:26 UTC